News on issues related to managing clinical laboratories.
How labs — including those that are part of other healthcare systems — offering PGx testing will react to Inova's decision to not engage with the FDA remains to be seen.
A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.
Pharmacogenetics and legal experts took particular issue with the agency's suggestion that "established" drug/gene relationships are found only in FDA-approved drug labels.
A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.
CMS had received significant stakeholder feedback that germline NGS testing is not the same as somatic testing, and that the NCD as written would negatively impact patients.
